The upcoming Greater Philadelphia Business Coalition on Health (GPBCH) 2024 Mental Health Summit aims to address the growing recognition among employers of the critical role mental health plays in workplace productivity and overall well-being.
The upcoming Greater Philadelphia Business Coalition on Health (GPBCH) 2024 Mental Health Summit aims to address the growing recognition among employers of the critical role mental health plays in workplace productivity and overall well-being, according to GPBCH President and CEO Neil Goldfarb.
Over the past decade, workplace culture has shifted from focusing primarily on physical health to embracing a more holistic view of well-being, including mental health. Employers now understand that addressing mental health concerns, like depression and anxiety, can reduce both direct and indirect costs while fostering a healthier, more productive workforce. However, many still struggle with effectively implementing strategies that create a supportive culture and leverage existing resources like Employee Assistance Programs (EAPs). This summit seeks to provide practical solutions and tools to address these challenges.
The event will feature a 3-part agenda designed to guide employers through understanding workforce mental health needs, building a culture around health, and exploring innovative treatment approaches. The program includes sessions on generational differences in mental health needs, the role of coaching and peer support, and advancements such as prescription digital therapeutics and psychedelics.
The daylong meeting will conclude with a panel of employers sharing their experiences, challenges, and best practices. Attendees will leave with actionable strategies to enhance mental health support in the workplace, often by maximizing existing resources in innovative ways.
Politics vs Science: The Future of US Public Health
February 4th 2025On this episode of Managed Care Cast, we speak with Perry N. Halkitis, PhD, MS, MPH, dean of the Rutgers School of Public Health, on the public health implications of the US withdrawal from the World Health Organization and the role of public health leaders in advocating for science and health.
Listen
Phase 1 Study Identifies Casdatifan Dose With Promising Responses in Pretreated Clear Cell RCC
February 18th 2025Casdatifan targets a transcription factor that binds with other proteins to switch off the body’s anti-inflammatory mechanisms, empowering genes that promote tumor growth in clear cell renal cell carcinoma (RCC).
Read More